Friday, 25 May 2018

You are here

Educational Intervention Facilitates Treat-to-Target Management in Rheumatoid Arthritis

Treat-to-target (TTT) has become a goal in rheumatoid arthritis (RA) therapeutics, but its implementation in daily practice is varied and viewed to be difficult by most. Solomon and coworkers have shown that TTT education through group-based quality improvement sessions can result in wider use of TTT in practice.

They set out to study the adherence to TTT in practice using a randomized quality improvement intervention with wait-list control across 11 rheumatology sites in the US.

The intervention utilized was a "learning collaborative" effort to establish best practices. These group-based learning collaboratives used rapid cycle testing for change along with frequent assessment of quality care improvements.

For 9-months the LC group incorporated rapid-cycle improvement methods. A composite TTT implementation score was a percentage of four required items documented in the chart. These included: 1) a disease activity target; 2) recording RA disease activity,numerically or by category (i.e., remission, low disease activity, etc.) using either the DAS28, SDAI, CDAI, or RAPID3; 3) documenting shared-decision making; and 4) documenting treatment decisions based on target and disease activity measure.

Five sites (23 providers) were randomized to intervention  and managed 320 patients, while six sites (23 provider) were randomized to the wait-list control, managing 321 patients.

At study start a minority utilized TTT with mean TTT implementation score of 11%.  After  9 months, the TTT implementation score was higher with the LC intervention (57% vs 25% in control).

Substantial improvement in TTT utilization was seen with this learning collaborative intervention.  

While nearly half of all rheumatologists utilize some disease measure in practice, there is little evidence that they utilize this information in daily patient management.  These findings suggest that knowing and using the measure in the clinic may not be enough and that a substantial committment to quality care and specific educational interventions are needed to demonstrate treatment decisions based on disease activity measures in RA.

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Autoinflammatory Syndromes Show Dramatic Response to Canakinumab

The New England Journal of Medicine reports that the anti-interleukin (IL)-1β monoclonal antibody canakinumab (Ilaris) was effective in the treatment of three distinct autoinflammatory recurrent fever syndromes (FMF, TRAPS, HIDS) with responses that were far superior to what was seen with placebo on almost every outcome measure, a randomized study found.

Treat-to-Target a Bust with Rheumatologists

Treat-to-target strategy is widely advocated as an important means of optimizing treatment responses in patients with rheumatoid arthritis. Even though T2T is encouraged by most guidelines, a current report shows that US Rheumatologists fail to implement T2T in their daily practice.

Epigenetic Link in Rheumatoid Arthritis to Huntington's Disease

Researchers at University of California San Diego School and the Icahn School of Medicine have found a high-resolution epigenomic landscape of rheumatoid arthritis (RA) that overlaps with that seen in Huntington's disease, suggesting potentially new unanticipated pathways that could be developed into therapeutic targets.

Mortality Predictors in Rheumatoid Arthritis

A population based study from southern Denmark finds excess mortality RF-positive males with rheumatoid arthritis (RA) and that employment status and comorbidity were independent predictors of mortality.

Investigators stuided 509 RA patients between 1995 to 2002, of whom 200 (39%) died during 6079 person-years of follow-up.

Genetic Breakthrough in Systemic JIA

The identification of a genetic susceptibility locus for systemic juvenile idiopathic arthritis (sJIA) has important implications for treatment of this severe, poorly understood illness, researchers reported.